BREAKWATER: Analysis of first-line encorafenib + cetuximab + chemotherapy in BRAF V600E-mutant metastatic colorectal cancer - Kopetz, S; Yoshino, T; Van Cutsem, E
Oral abstract session ASCO GI 2025 San Francisco